Pegylated liposomal doxorubicin replacing conventional doxorubicin in standard R-CHOP chemotherapy for elderly patients with diffuse large B-cell lymphoma: an open label, single arm, phase II trial.
暂无分享，去创建一个
Michael L. Wang | Y. Oki | P. Mclaughlin | Xuelin Huang | A. Younes | L. Kwak | D. Lenihan | J. Durand | L. Fayad | S. Neelapu | M. Fisch | A. Astrow | M. Ewer | M. Fanale | F. Hagemeister | B. Pro | M. Rodriguez | J. Romaguera | F. Samaniego | N. Fowler